Purchase Order 75N91018P00287

<p>The National Cancer Institute awarded a purchase order to Qlucore Inc. for $4,624.00 on March 13, 2018, with ultimate completion on April 13, 2018. No set-aside was used. Performance occurs in Bethesda, Maryland. The order procures scientific software licensing, specifically Qlucore Omics Explorer for data visualization and analysis in genomics and cancer research applications.</p>

<p>The National Cancer Institute awarded a purchase order to Qlucore Inc. for $23,596.00 on January 15, 2020, with final completion scheduled for February 17, 2020. No set-aside was used. Performance occurs in New York, New York. The order procures scientific software licensing, specifically Qlucore Omics Explorer with data analysis capabilities for research institutions. Pricing is firm fixed price.</p>

<p>Qlucore Inc. has been awarded a $23,600 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to deliver software. The contract has no set-aside designation and runs through January 23, 2025. Performance will take place in New York, New York to support the National Cancer Institute's research programs.</p>

This is a federal contract award to Qlucore Inc., a foreign-owned, for-profit organization, by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services. The contract provides Qlucore's Qlucore Omics Explorer software, including four academic floating licenses (four concurrent users) and one next-generation sequencing (NGS) add-on floating license. The total ceiling value of the contract is $21,860.00, and it is a firm-fixed-price purchase order....

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qlucore Inc. for $13,738.00 on August 23, 2019. The order, firm fixed price with no set-aside, covers Qlucore Omics Explorer software. Performance is located in New York, New York, with completion by August 31, 2020. The purchase order funds software licensing for research and data analysis purposes.</p>

This is a firm fixed-price purchase order award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Qlucore Inc., a foreign-owned, for-profit corporation. The award is for an academic floating license of Qlucore's Omics Explorer software, a data analysis tool used in research on fields such as genomics, cancer, infectious diseases, and aging. The contract has a ceiling value of $5,549.00 and an...

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $11,414.00 on March 20, 2018, with an ultimate completion date of April 20, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order is a firm fixed price commercial transaction. The specific commodity or service being procured is not detailed in the source.</p>

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC valued at $11,768.00 on April 15, 2019, with ultimate completion on April 14, 2020. No set-aside was used. Performance occurs in Bethesda, Maryland. The source does not specify the nature of goods or services procured or reference an originating solicitation.</p>

The National Cancer Institute awarded a purchase order to Qiagen, LLC for $4,995.00 on January 26, 2018, with completion scheduled for January 31, 2019. No set-aside was used. Performance takes place in Bethesda, Maryland. The order calls for firm fixed-price procurement of molecular diagnostics, scientific equipment, or bioinformatics solutions consistent with Qiagen's federal product portfolio of DNA and RNA extraction kits, next-generation sequencing supplies, sample preparation...

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $24,480.00 on March 30, 2020, with performance completion by March 31, 2021. Work is performed in Bethesda, Maryland. This firm fixed-price purchase order acquired molecular diagnostics products or services—specific scope details are not provided in the award documentation.</p>